Takeda to move U.S. headquarters to Boston, affecting 1,000 employees
As Takeda works to close its acquisition of Shire, the company plans to move its Chicago-area U.S. headquarters and center its U.S. operations in the Boston area where Shire has operations. This move will affect 1,000 employees and will also position its business near the former headquarters of Ariad, a biotech that Takeda purchased last year for $5.2B.
